Profiles

Keywords
Last Name
Institution

Martin Hertl

Concepts (324)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
28
2018
112
5.530
Why?
Liver
13
2019
213
2.360
Why?
Kidney Transplantation
10
2021
153
2.000
Why?
Living Donors
9
2011
17
1.530
Why?
Portal Vein
7
2018
50
1.450
Why?
Hepatectomy
7
2018
68
1.350
Why?
Carcinoma, Hepatocellular
6
2021
44
1.310
Why?
Liver Neoplasms
6
2021
122
1.210
Why?
Galactosyltransferases
3
2013
3
0.870
Why?
Liver Failure, Acute
4
2018
5
0.870
Why?
Gallstones
1
2021
8
0.850
Why?
Pancreatitis
1
2021
24
0.840
Why?
Transplantation, Heterologous
3
2016
25
0.720
Why?
Hepatomegaly
1
2018
6
0.690
Why?
Humans
58
2022
32988
0.670
Why?
Organ Preservation
3
2011
9
0.660
Why?
Swine
9
2018
116
0.660
Why?
Tissue Donors
3
2021
85
0.610
Why?
Liver Regeneration
4
2017
29
0.610
Why?
Kidney Failure, Chronic
7
2020
188
0.580
Why?
Male
39
2021
17726
0.530
Why?
Retrospective Studies
16
2022
3835
0.510
Why?
Neuroendocrine Tumors
3
2019
51
0.500
Why?
Middle Aged
29
2020
11219
0.500
Why?
Bile Ducts
2
2011
14
0.480
Why?
BK Virus
1
2013
13
0.470
Why?
Constriction, Pathologic
2
2019
43
0.470
Why?
Carcinoma, Transitional Cell
1
2013
17
0.460
Why?
Perfusion
2
2011
24
0.450
Why?
Kidney Neoplasms
1
2013
77
0.440
Why?
Animals
15
2021
5371
0.440
Why?
Hypertension, Malignant
1
2012
2
0.440
Why?
Protein S Deficiency
1
2011
2
0.430
Why?
Organ Transplantation
2
2021
43
0.410
Why?
Hypercholesterolemia
1
2011
39
0.410
Why?
Arteriovenous Shunt, Surgical
2
2022
23
0.410
Why?
Mesentery
1
2011
5
0.410
Why?
Peritoneal Neoplasms
1
2011
6
0.410
Why?
Ligation
4
2018
38
0.410
Why?
Carcinoid Tumor
1
2011
21
0.400
Why?
Female
29
2021
18423
0.400
Why?
Pancreas
2
2021
39
0.380
Why?
Decision Support Techniques
1
2010
57
0.380
Why?
Kidney
4
2021
219
0.380
Why?
Intestines
1
2011
115
0.380
Why?
Endothelial Cells
1
2010
69
0.370
Why?
Adrenal Cortex Neoplasms
2
2020
13
0.370
Why?
Adrenocortical Carcinoma
2
2020
12
0.370
Why?
Postoperative Complications
9
2022
1117
0.350
Why?
Pancreatic Neoplasms
3
2019
176
0.340
Why?
Gastrointestinal Stromal Tumors
1
2008
9
0.340
Why?
Bile Duct Neoplasms
2
2005
14
0.330
Why?
Food Hypersensitivity
1
2009
57
0.330
Why?
Hepatopulmonary Syndrome
1
2008
1
0.330
Why?
Informed Consent
2
2005
25
0.320
Why?
Tissue and Organ Harvesting
3
2004
23
0.320
Why?
Gynecomastia
1
2007
1
0.320
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2007
15
0.310
Why?
Treatment Outcome
14
2022
4036
0.310
Why?
Incidental Findings
1
2007
20
0.310
Why?
Hepatitis C
1
2008
70
0.310
Why?
Breast Neoplasms
2
2011
435
0.300
Why?
Neoplasm Staging
4
2019
457
0.300
Why?
Graft Survival
8
2016
110
0.290
Why?
Biliary Tract Diseases
2
2019
7
0.290
Why?
Survival Rate
6
2020
443
0.290
Why?
Tissue and Organ Procurement
2
2003
37
0.290
Why?
Coccidioides
1
2006
3
0.290
Why?
Coccidioidomycosis
1
2006
8
0.290
Why?
Time Factors
7
2022
1873
0.280
Why?
Registries
1
2007
226
0.270
Why?
Liver Diseases
2
2017
47
0.270
Why?
Directed Tissue Donation
1
2005
1
0.270
Why?
Donor Selection
1
2005
1
0.270
Why?
Physician-Patient Relations
1
2005
47
0.260
Why?
Cholangiopancreatography, Endoscopic Retrograde
2
2021
11
0.250
Why?
Adult
13
2020
9848
0.250
Why?
Hepatitis B, Chronic
1
2003
7
0.250
Why?
Postoperative Hemorrhage
2
2014
29
0.240
Why?
Biliary Tract Surgical Procedures
2
2019
4
0.240
Why?
Communication
1
2005
133
0.240
Why?
Papio hamadryas
2
2013
2
0.240
Why?
Swine, Miniature
2
2013
9
0.240
Why?
Liver Function Tests
4
2015
29
0.240
Why?
Venous Thrombosis
2
2019
55
0.230
Why?
Incidence
3
2021
840
0.230
Why?
Gastroparesis
1
2022
3
0.220
Why?
Arteriovenous Fistula
1
2022
12
0.220
Why?
Aneurysm
1
2022
20
0.220
Why?
Random Allocation
3
2018
162
0.220
Why?
Pancreaticoduodenectomy
1
2022
31
0.220
Why?
Urogenital Abnormalities
1
2021
7
0.220
Why?
Pancreas Transplantation
1
2021
17
0.210
Why?
Infertility, Female
1
2021
23
0.210
Why?
Cholecystectomy
1
2021
19
0.210
Why?
Hospitals, University
1
2001
44
0.210
Why?
Specialization
1
2001
22
0.210
Why?
Raffinose
1
2001
2
0.210
Why?
Organ Preservation Solutions
1
2001
2
0.210
Why?
Ursodeoxycholic Acid
1
2001
3
0.210
Why?
Glutathione
1
2001
31
0.210
Why?
Allopurinol
1
2001
6
0.210
Why?
Organ Size
2
2018
119
0.210
Why?
Xenograft Model Antitumor Assays
1
2021
29
0.210
Why?
Adenosine
1
2001
16
0.210
Why?
Immunoglobulin G
2
2013
149
0.210
Why?
Graft vs Host Disease
1
2021
60
0.210
Why?
Transplant Recipients
1
2021
26
0.200
Why?
Bone Marrow Transplantation
2
2013
41
0.200
Why?
Ultrasonography
3
2018
215
0.200
Why?
Antineoplastic Agents
2
2021
244
0.200
Why?
Follow-Up Studies
5
2020
2053
0.200
Why?
Surgical Instruments
1
2020
30
0.200
Why?
Renal Dialysis
4
2022
132
0.200
Why?
Gene Expression Regulation, Neoplastic
1
2021
126
0.200
Why?
Insulin
1
2001
117
0.190
Why?
Hepatic Veins
2
2018
10
0.190
Why?
Adrenalectomy
1
2019
5
0.190
Why?
Health Care Costs
1
2020
83
0.190
Why?
Jejunostomy
1
2019
9
0.190
Why?
Prognosis
4
2020
1011
0.190
Why?
Pancreatectomy
1
2019
16
0.180
Why?
Chemotherapy, Adjuvant
1
2019
90
0.180
Why?
Suture Techniques
1
2020
149
0.180
Why?
Breast Implants
3
2011
8
0.180
Why?
Cholagogues and Choleretics
1
1999
1
0.180
Why?
Taurochenodeoxycholic Acid
1
1999
2
0.180
Why?
Reperfusion Injury
1
1999
7
0.180
Why?
Abdominal Neoplasms
1
2019
12
0.180
Why?
Heat Stroke
1
2018
1
0.170
Why?
Intestinal Neoplasms
1
2018
13
0.170
Why?
Digestive System Surgical Procedures
1
2018
27
0.170
Why?
Liver Failure
1
2018
13
0.170
Why?
Patient Compliance
1
2020
200
0.170
Why?
Hospitalization
1
2021
367
0.170
Why?
Papio
3
2016
12
0.170
Why?
Pulmonary Embolism
1
2019
58
0.170
Why?
Stomach Neoplasms
1
2018
41
0.170
Why?
Child, Preschool
2
2013
798
0.170
Why?
Venous Thromboembolism
1
2019
58
0.160
Why?
Hypertrophy
1
2017
25
0.160
Why?
Neovascularization, Physiologic
1
2017
30
0.160
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2018
86
0.160
Why?
Vascular Patency
4
2022
31
0.150
Why?
Aged
11
2020
10542
0.150
Why?
Prostatic Neoplasms
1
2017
125
0.140
Why?
Gene Knockout Techniques
2
2013
12
0.140
Why?
Patient Selection
4
2019
261
0.140
Why?
Thrombocytopenia
2
2014
31
0.140
Why?
Graft Occlusion, Vascular
2
2022
29
0.140
Why?
Tobacco Use Disorder
1
2015
20
0.140
Why?
Kaplan-Meier Estimate
2
2019
216
0.140
Why?
Jaundice, Obstructive
1
2015
1
0.140
Why?
Cysts
1
2015
21
0.130
Why?
Biopsy
2
2013
277
0.130
Why?
Disease Models, Animal
1
2018
844
0.130
Why?
Graft Rejection
4
2020
87
0.130
Why?
Liver Cirrhosis
1
2014
61
0.130
Why?
Antibodies, Heterophile
1
2013
1
0.120
Why?
Heterografts
1
2013
17
0.120
Why?
Heart Transplantation
1
2014
51
0.120
Why?
Heart-Assist Devices
1
2014
32
0.120
Why?
Creatinine
1
2013
59
0.120
Why?
Hematoma
1
2013
25
0.120
Why?
Immunosuppressive Agents
3
2020
166
0.120
Why?
Ureterostomy
1
2012
1
0.110
Why?
Cystostomy
1
2012
4
0.110
Why?
Polytetrafluoroethylene
2
2011
8
0.110
Why?
Magnetic Resonance Imaging
3
2015
1315
0.110
Why?
Ureter
1
2012
27
0.110
Why?
Blood Vessel Prosthesis
2
2011
27
0.110
Why?
Protein S
1
2011
2
0.110
Why?
Hepatic Encephalopathy
1
2012
7
0.110
Why?
Neoplasm Metastasis
2
2018
120
0.110
Why?
Warm Ischemia
1
2011
2
0.110
Why?
Bile
1
2011
6
0.110
Why?
Intracranial Hypertension
1
2012
14
0.110
Why?
Intracranial Pressure
1
2012
26
0.110
Why?
Bilirubin
1
2011
11
0.110
Why?
Alkaline Phosphatase
1
2011
18
0.110
Why?
Breast Implantation
1
2011
4
0.110
Why?
Hepatitis, Autoimmune
1
2011
9
0.110
Why?
Databases, Factual
3
2019
393
0.110
Why?
Monitoring, Intraoperative
1
2012
43
0.110
Why?
Hemodynamics
1
2011
100
0.100
Why?
Mastectomy
1
2011
34
0.100
Why?
Endoscopy, Digestive System
1
2011
10
0.100
Why?
Intestinal Obstruction
1
2011
15
0.100
Why?
Waiting Lists
2
2014
18
0.100
Why?
Energy Metabolism
1
2011
82
0.100
Why?
Oxygen
1
2011
105
0.100
Why?
Gastrointestinal Hemorrhage
1
2011
29
0.100
Why?
Complement C3a
1
2010
3
0.100
Why?
Complement Activation
1
2010
15
0.100
Why?
Cytotoxicity, Immunologic
1
2010
33
0.100
Why?
Immunoglobulin M
1
2010
23
0.100
Why?
End Stage Liver Disease
1
2010
18
0.100
Why?
Transplantation, Autologous
1
2011
221
0.100
Why?
Tissue Engineering
1
2010
50
0.090
Why?
Rats
3
2016
972
0.090
Why?
Tomography, X-Ray Computed
2
2015
899
0.090
Why?
Anaphylaxis
1
2009
11
0.090
Why?
Fatal Outcome
1
2009
76
0.090
Why?
Nephrectomy
1
2009
43
0.090
Why?
Survival Analysis
3
2018
372
0.090
Why?
Risk Factors
3
2022
2762
0.090
Why?
Neoplasm Recurrence, Local
1
2010
244
0.090
Why?
Models, Animal
2
2016
147
0.090
Why?
Hemophilia A
1
2008
43
0.080
Why?
Young Adult
2
2020
2287
0.080
Why?
Transplantation Chimera
1
2008
3
0.080
Why?
Transplantation Tolerance
1
2008
4
0.080
Why?
Cadaver
1
2009
366
0.080
Why?
United States
3
2020
2632
0.080
Why?
Multivariate Analysis
2
2019
386
0.080
Why?
Colonoscopy
1
2008
90
0.080
Why?
Rats, Wistar
2
2017
64
0.080
Why?
Reoperation
1
2012
970
0.080
Why?
New England
1
2006
4
0.070
Why?
Cholangitis, Sclerosing
1
2006
4
0.070
Why?
Hepatoblastoma
1
2005
1
0.070
Why?
Blood Coagulation Factors
2
2016
20
0.070
Why?
Hemangioendothelioma, Epithelioid
1
2005
3
0.070
Why?
Cystic Duct
1
2005
1
0.070
Why?
Cholangiocarcinoma
1
2005
13
0.070
Why?
Coercion
1
2005
7
0.070
Why?
Cholestasis
1
2005
9
0.070
Why?
Social Values
1
2005
11
0.070
Why?
Interview, Psychological
1
2005
45
0.070
Why?
Postoperative Period
2
2019
298
0.070
Why?
Medical Oncology
1
2005
37
0.070
Why?
Liver Circulation
2
2017
7
0.060
Why?
Animals, Genetically Modified
2
2014
18
0.060
Why?
Adenoma
1
2005
63
0.060
Why?
Referral and Consultation
1
2005
102
0.060
Why?
Combined Modality Therapy
2
2019
449
0.060
Why?
Anastomosis, Surgical
2
2019
57
0.060
Why?
Contrast Media
1
2004
148
0.060
Why?
Decision Making
1
2005
239
0.060
Why?
Pancreatic Fistula
1
2022
3
0.050
Why?
Steroids
1
2022
31
0.050
Why?
Uterus
1
2021
27
0.050
Why?
Hysterectomy
1
2021
24
0.050
Why?
Naphthoquinones
1
2021
6
0.050
Why?
Rats, Inbred Lew
1
2001
13
0.050
Why?
Benzofurans
1
2021
8
0.050
Why?
Aniline Compounds
1
2021
41
0.050
Why?
Sulfonamides
1
2021
60
0.050
Why?
In Vitro Techniques
1
2001
244
0.050
Why?
Cost Savings
1
2020
42
0.050
Why?
Cost-Benefit Analysis
1
2020
159
0.050
Why?
Mitotane
1
2019
3
0.050
Why?
Quality Improvement
1
2022
173
0.050
Why?
Diagnosis, Differential
2
2013
462
0.050
Why?
Lymphatic Metastasis
1
2020
101
0.050
Why?
Tumor Burden
1
2019
38
0.050
Why?
Disease-Free Survival
1
2019
228
0.040
Why?
Blood Coagulation Disorders
1
2019
18
0.040
Why?
Serum Albumin
1
2019
31
0.040
Why?
Cyclosporine
1
1999
20
0.040
Why?
Operative Time
1
2019
96
0.040
Why?
Proportional Hazards Models
1
2019
387
0.040
Why?
Prostate-Specific Antigen
1
2017
19
0.040
Why?
Portal Pressure
1
2017
6
0.040
Why?
Fungi
1
1997
6
0.040
Why?
Dose-Response Relationship, Drug
1
2018
494
0.040
Why?
Adolescent
2
2020
2687
0.040
Why?
Anticoagulants
1
2019
153
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
378
0.040
Why?
Hyperplasia
1
2017
25
0.040
Why?
Bacteria
1
1997
82
0.040
Why?
Practice Guidelines as Topic
1
2019
388
0.040
Why?
Cell Hypoxia
1
2016
17
0.040
Why?
Paecilomyces
1
1995
3
0.040
Why?
Policy
1
2015
11
0.040
Why?
Mice
1
2021
1958
0.030
Why?
Mycoses
1
1995
23
0.030
Why?
Brain
1
2006
1752
0.030
Why?
Chicago
1
2018
957
0.030
Why?
Smoking Cessation
1
2015
54
0.030
Why?
Blood Transfusion
1
2014
70
0.030
Why?
Smoking
1
2015
206
0.030
Why?
Risk Assessment
1
2017
814
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2013
9
0.030
Why?
Attitude of Health Personnel
1
2015
189
0.030
Why?
Cardiovascular Diseases
1
2018
446
0.030
Why?
Immunity, Cellular
1
2013
71
0.030
Why?
Stents
1
2015
159
0.030
Why?
Prosthesis-Related Infections
1
1995
217
0.030
Why?
Cohort Studies
1
2018
2077
0.030
Why?
Massachusetts
1
2011
24
0.030
Why?
Biocompatible Materials
1
2011
122
0.020
Why?
Hepatocytes
1
2010
12
0.020
Why?
Extracellular Matrix
1
2010
91
0.020
Why?
Aged, 80 and over
1
2020
5249
0.020
Why?
Patient Education as Topic
1
2011
193
0.020
Why?
Angiography
1
2009
58
0.020
Why?
Factor VIII
1
2008
27
0.020
Why?
Blood Loss, Surgical
1
2008
69
0.020
Why?
Hemorrhage
1
2008
95
0.020
Why?
Hepatocyte Nuclear Factor 3-alpha
1
2008
1
0.020
Why?
Transplantation Immunology
1
2008
3
0.020
Why?
Histocompatibility Testing
1
2008
6
0.020
Why?
Granzymes
1
2008
8
0.020
Why?
Transplantation Conditioning
1
2008
47
0.020
Why?
Hepatitis C, Chronic
1
2008
81
0.020
Why?
Laparoscopy
1
2009
193
0.020
Why?
T-Lymphocytes
1
2008
229
0.020
Why?
RNA, Messenger
1
2008
376
0.020
Why?
Transplantation, Homologous
1
2008
297
0.020
Why?
Sodium Chloride
2
1997
45
0.020
Why?
Vena Cava, Inferior
1
2006
13
0.020
Why?
Prospective Studies
1
2011
2002
0.020
Why?
Syndrome
1
2005
101
0.020
Why?
Biliary Tract
1
2004
3
0.020
Why?
Cholangiopancreatography, Magnetic Resonance
1
2004
4
0.020
Why?
Hepatic Artery
1
2004
3
0.020
Why?
Magnetic Resonance Angiography
1
2004
51
0.020
Why?
Preoperative Care
1
2004
148
0.010
Why?
Imaging, Three-Dimensional
1
2004
235
0.010
Why?
Forecasting
1
2001
136
0.010
Why?
Silicone Elastomers
1
1997
3
0.010
Why?
Culture Media
1
1997
44
0.010
Why?
Rabbits
1
1997
336
0.010
Why?
Hertl's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description